Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Eyeonics Eyes International Sales Force Creation With Planned IPO Proceeds

This article was originally published in The Gray Sheet

Executive Summary

Premium intraocular lens maker Eyeonics will establish a direct sales force outside the United States and expand its domestic sales and marketing activities with the proceeds of a planned initial public stock offering

You may also be interested in...

Intraocular Lens Makers See Unmet Need For Fully “Accommodating” Product

Integrating the merits of various intraocular lens (IOL) implants into a single "accommodating" IOL remains the Holy Grail of eye care companies

Medicare To Pay For Presbyopia IOLs; Firms Prepare Marketing Blitz

Presbyopia intraocular lens manufacturers will now be able to target the more than 2 mil. cataract surgery patients served by Medicare, following CMS' ruling to allow partial payment for the lenses

CrystaLens Accommodating IOL First To Market; Firm Eyes Expanded Labeling

Eyeonics, Inc. will file a supplemental PMA for its CrystaLens AT-45 accommodating posterior chamber intraocular lens to broaden the treatment range beyond 1.0 diopter

Related Content




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts